CDK1 and neoplasm: We analyzed differential phosphopeptide abundance between 80 tumor/NAT paired tissues to stratify phospho-substrates corresponding to different kinases and their inhibitors, and identified CDK1 and MAPK1 (ERK2) as two highly ranked phospho-substrate events in most tumors.